What to expect in the LivaNova PLC interview process

Based on publicly available sources, LivaNova PLC is a global medical technology and device manufacturer originally formed in 2015 from the merger of Sorin S.p.A. and Cyberonics Inc. Headquartered in London, United Kingdom, the company trades on the NASDAQ under the ticker LIVN and maintains a market capitalization of approximately $2.5B to $4.5B, with annual revenues around $1B to $1.4B.

The company employs roughly 3,000 to 4,700 people globally across roughly 48 to over 100 countries, with major operational hubs including the United States, Italy, France, Germany, and Brazil. Its workforce has experienced modest multi-year growth of about 4% to 9%. LivaNova operates primarily through three business segments: Cardiopulmonary (producing heart-lung machines, oxygenators, and perfusion systems), Neuromodulation (featuring VNS Therapy systems), and Advanced Circulatory Support.

Publicly available corporate descriptions emphasize a mission centered on patient outcomes, clinical and economic value, and an internal culture that encourages employees to challenge the status quo and collaborate within specialized teams. Leadership includes CEO Vladimir Makatsaria, Chief Human Resources Officer Natalia Kozmina, and Chief Innovation Officer Ahmet Tezel. Active hiring persists across global markets, though specific internal metrics regarding interview durations, strict monitoring policies, or day-to-day management styles are not heavily detailed in current workforce data.